Sort Through Options for Meningococcal Vaccination
July 2025
MenQuadfi quadrivalent conjugate vaccine will give us another option for meningococcal immunization.
It will join other quadrivalent options Menactra, Menveo, and Nimenrix...but expect Menactra to be phased out this year.
Meningococcal disease is rare. But about 10% of cases are fatal...and up to 20% result in long-term complications, such as brain damage.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive